Investment Rating - The investment rating for the company is maintained as "Buy" with a target price of RMB 16.10 [1]. Core Views - The company is currently at a low point in its fundamentals, but several positive factors are accumulating. Inventory destocking by downstream major clients is nearing its end, and there is limited downside for the company's profitability and order prices, with potential for improvement. The new factory in Malaysia, market entry in the US, and new product lines are expected to contribute positively. Therefore, it is anticipated that the company's sales will recover to positive growth in 2026, with price stabilization and improvement potential [1][6][9]. Summary by Sections Supply and Demand - The destocking effect from downstream clients is expected to diminish, leading to a recovery in demand. The company's revenue decline has narrowed significantly, and the impact of destocking is gradually weakening, which may drive a gradual recovery in orders [7]. Price Dynamics - The company’s main raw materials are linked to oil prices, and recent geopolitical tensions have caused international oil prices to rise. This, combined with pre-holiday inventory replenishment, has improved the price differentials of most chemical products. Therefore, there is limited room for further price declines, with potential for upward price adjustments [8]. Sales Growth Potential - The new factory in Malaysia is nearing completion, with trial production preparations underway. The company is also promoting new products such as amino acid surfactants and anti-dandruff agents, which are entering major brand supply chains. Additionally, the US FDA certification for P-S products is progressing, which could open new growth avenues in the US market, the largest sunscreen market globally [9]. Profit Forecast and Valuation - The forecast for net profit attributable to the parent company for 2025E-2027E is maintained at RMB 0.87 billion, RMB 1.64 billion, and RMB 2.47 billion, respectively. The target price has been adjusted to RMB 16.10, reflecting a 31x PE for 2027E, based on clear expectations for supply-demand improvement, potential price increases, and anticipated sales growth [10].

Core Viewpoint - Koss Corporation, known as the "first stock in beauty sunscreen," is experiencing a significant decline in performance, with a projected net profit drop of 78.67% to 84% in 2025 due to decreased sales volume and market price of sunscreen products [1][2]. Financial Performance - In 2024, Koss Corporation's revenue decreased by 5.16% to approximately 2.28 billion yuan, while net profit fell by 23.33% to about 562 million yuan [4][5]. - For the first half of 2025, revenue and net profit are expected to decline by 48.67% and 84.51%, respectively, reaching 721 million yuan and approximately 65 million yuan [6]. - The company's gross profit margin decreased to 44.4% in 2024 due to price reductions in some sunscreen products [5]. Market Dynamics - The sunscreen market is stabilizing after rapid growth, leading to increased competition and a more balanced supply-demand relationship [2][3]. - Koss Corporation's reliance on international markets is significant, with over 86% of its revenue coming from overseas clients [10]. Product Performance - Sunscreen products are the main revenue drivers for Koss Corporation, and any changes in their sales volume and pricing significantly impact the company's overall performance [8][10]. - In the first half of 2025, revenue from cosmetic active ingredients decreased by 54.76%, accounting for approximately 75.4% of total revenue [10]. Strategic Initiatives - Koss Corporation plans to enhance market development efforts, focusing on collaboration with small and medium-sized clients and increasing investment in cosmetic formulation and application research [5][11]. - The company is expanding its product line to include amino acid surfactants and other personal care ingredients to seek new growth opportunities [11]. Research and Development - Despite emphasizing technology innovation, Koss Corporation's R&D expenditure has decreased, with a 39.91% drop in the first half of 2025 compared to the previous year [11].

Core Viewpoint - The company, Keshare Co., has expanded its product offerings in the personal care sector, leveraging its strengths in sunscreen agents to include amino acid surfactants and pyrithione ethanolamine salt (PO) [1] Group 1 - The company has successfully entered the supply chains of leading brands such as Unilever [1] - Sales promotion for the new product lines is progressing in an orderly manner [1]

Core Viewpoint - Koshi Co., Ltd. (科思股份) is facing significant challenges in its business performance, particularly in its sunscreen product segment, leading to a substantial decline in projected profits for 2025 [1][2] Financial Performance - For 2025, the company forecasts a net profit attributable to shareholders between 90 million to 120 million yuan, representing a year-on-year decline of 78.67% to 84% [1] - In the first three quarters of 2025, the company reported operating revenue of 1.116 billion yuan, down 39.93% year-on-year, with a net profit of approximately 77.93 million yuan, a decrease of 84.84% [2] - The gross margin fell from 48.8% in 2023 to 29.7% in the first three quarters of 2025, while the net margin dropped from 30.6% to 6.6% in the same period [2] Business Segment Insights - The core product line of the company includes "active ingredients and raw materials for cosmetics," with sunscreen agents being the primary focus, accounting for over 80% of total revenue [2] - Revenue from this segment decreased from 2.07 billion yuan in 2023 to 1.904 billion yuan in 2024, and more than 54% in the first half of 2025 [2] Market Dynamics - The global sunscreen market is experiencing a slowdown, with the market size reaching 15.287 billion USD in 2023 and an average annual growth rate of approximately 7.6% from 2021 to 2023, which is expected to decline to 4.3% from 2023 to 2028 [5] - Increased competition in the sunscreen market has led to a general decline in product prices, impacting profit margins [5] Competitive Landscape - The company is a major manufacturer of sunscreen agents, holding over 20% market share in 2023, with key clients including global giants like L'Oréal, Procter & Gamble, and Bayer [3] - The company’s overseas business accounted for 89.94% of its revenue in 2023, although this proportion decreased to 86.97% in 2024, with a significant drop in overseas revenue in the first half of 2025 [3][4] Strategic Initiatives - The company is accelerating the construction of a 10,000-ton annual production project for sunscreen products in Malaysia to enhance its supply response capabilities in the European and Southeast Asian markets [3]

科思股份(300856.SZ)披露2025年度业绩预告，公司预计归属于上市公司股东的净利润9000万元至1.2亿 元，同比下降78.67%至84.00%;扣除非经常性损益后的净利润8500万元至1.15亿元，同比下降78.31%至 83.97%。 科思股份(300856.SZ)披露2025年度业绩预告，公司预计归属于上市公司股东的净利润9000万元至1.2亿 元，同比下降78.67%至84.00%;扣除非经常性损益后的净利润8500万元至1.15亿元，同比下降78.31%至 83.97%。 报告期内，受防晒市场需求增长放缓和下游客户消化前期库存的影响，导致公司防晒剂出货量较上年同 期有所下降;同时受客户去库存和市场竞争增加的影响，报告期内防晒剂产品市场价格较去年同期有所 回落，进而降低了本期归属于上市公司股东的净利润。 ...

报告期内，受防晒市场需求增长放缓和下游客户消化前期库存的影响，导致公司防晒剂出货量较上年同 期有所下降;同时受客户去库存和市场竞争增加的影响，报告期内防晒剂产品市场价格较去年同期有所 回落，进而降低了本期归属于上市公司股东的净利润。 科思股份(300856.SZ)披露2025年度业绩预告，公司预计归属于上市公司股东的净利润9000万元至1.2亿 元，同比下降78.67%至84.00%;扣除非经常性损益后的净利润8500万元至1.15亿元，同比下降78.31%至 83.97%。 ...

科思股份公告，预计2025年度归属于上市公司股东的净利润9000万元-1.2亿元，同比下降 78.67%-84.00%。报告期内，受防晒市场需求增长放缓和下游客户消化前期库存的影响，导致公司防晒 剂出货量较上年同期有所下降；同时受客户去库存和市场竞争增加的影响，报告期内防晒剂产品市场价 格较去年同期有所回落，进而降低了本期归属于上市公司股东的净利润。2025年度，预计非经常性损益 对公司净利润的影响额约为500万元，主要系计入当期损益的政府补助以及非流动性资产的处置所致。 ...

南财智讯1月21日电，科思股份发布年度业绩预告，预计2025年全年归属于上市公司股东的净利润为 9000万元—12000万元，同比预减78.67%—84.00%；预计2025年全年归属于上市公司股东的扣除非经常 性损益的净利润为8500万元—11500万元，同比预减78.31%—83.97%；报告期内，受防晒市场需求增长 放缓和下游客户消化前期库存的影响，导致公司防晒剂出货量较上年同期有所下降；同时受客户去库存 和市场竞争增加的影响，报告期内防晒剂产品市场价格较去年同期有所回落，进而降低了本期归属于上 市公司股东的净利润。2025年度，预计非经常性损益对公司净利润的影响额约为500万元，主要系计入 当期损益的政府补助以及非流动性资产的处置所致。 ...

报告期内，受防晒市场需求增长放缓和下游客户消化前期库存的影响，导致公司防晒剂出货量较上年同 期有所下降；同时受客户去库存和市场竞争增加的影响，报告期内防晒剂产品市场价格较去年同期有所 回落，进而降低了本期归属于上市公司股东的净利润。2025年度，预计非经常性损益对公司净利润的影 响额约为500万元，主要系计入当期损益的政府补助以及非流动性资产的处置所致。 格隆汇1月21日丨科思股份(300856.SZ)公布，预计2025年归属于上市公司股东的净利润9,000万元– 12,000万元，比上年同期下降78.67%-84.00%，扣除非经常性损益后的净利润8,500万元–11,500万元，比 上年同期下降78.31%-83.97%。 ...

人民财讯1月21日电，科思股份（300856）1月21日披露业绩预告，预计2025年归母净利润9000万元— 1.2亿元，同比下降78.67%—84%。报告期内，受防晒市场需求增长放缓和下游客户消化前期库存的影 响，公司防晒剂出货量较上年同期有所下降；同时受客户去库存和市场竞争增加的影响，报告期内防晒 剂产品市场价格较上年同期有所回落，进而降低了本期归属于上市公司股东的净利润。 ...